Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Indian Journal of Experimental Biology|October 1, 1996
A simple quantitative in vitro macrophage migration assayK K Bhopale, K B Masani, K S Pradhan, et al.
Phytotherapy Research : PTR|May 2, 2003
Protective effect of a polyherbal formulation (Immu-21) against cyclophosphamide-induced mutagenicity in miceG B Jena, Kumar V S Nemmani, C L Kaul, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 6, 2001
Evaluation of rifampicin bioequivalence in fixed-dose combinations using the WHO/IUATLD recommended protocolR Panchagnula, S Agrawal, K J Kaur, et al.
Current Opinion in Pulmonary Medicine|May 24, 2001
Antituberculosis drugs and new drug developmentS Agrawal, N S Thomas, A B Dhanikula, et al.
Pharmacological Research|October 27, 2004
Acute hyperglycemia attenuates nerve conduction velocity and nerve blood flow in male Sprague-Dawley rats: reversal by adenosineA K Saini, K H S Arun, C L Kaul, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 13, 2005
Minimum sample size and sampling time requirements for assessment of rifampicin bioequivalence from FDC formulationsS Agrawal, K J Kaur, I Singh, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1993
Pharmacokinetics and amoebicidal activity of (+-)-(E)-3-(4- methylsulphinylstyryl)-1,2,4-oxadiazole (BTI 2286E) and its sulphone metabolite (BTI 2571E) in the golden hamster, Mesocricetus auratusA Pargal, M G Kelkar, K K Bhopale, et al.
International Journal of Clinical Pharmacology and Therapeutics|October 25, 2002
Bioequivalence assessment of rifampicin, isoniazid and pyrazinamide in a fixed dose combination of rifampicin, isoniazid, pyrazinamide and ethambutol vs. separate formulationsS Agrawal, I Singh, K J Kaur, et al.
Annals of Tropical Medicine and Parasitology|April 1, 1993
Activity of a new oxadiazole compound, against experimental infections with Entamoeba histolytica and Giardia lamblia in animal modelsK K Bhopale, K S Pradhan, P G Phaltankar, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 29, 2005
Determination of rifampicin bioequivalence in a three-drug FDC by WHO and indian protocols: effect of sampling schedule and sizeS Agrawal, K J Kaur, I Singh, et al.
Pageof 5